Search for: "Sanofi"
Results 21 - 40
of 1,187
Sort by Relevance
|
Sort by Date
21 Jan 2024, 9:01 pm
Many of these cases have important implications for near-term merger reviews and enforcement actions including Sanofi/Maze Therapeutics (abandoned), a challenge to the license of a phase 2-ready pharmaceutical, traditionally viewed as likely too nascent to present a competitive issue; Amgen/Horizon Therapeutics (consent decree), a challenge focused on the parties’ ability to entrench the existing monopoly position of a non-overlap product; and Anesthesia Partners (ongoing), as… [read post]
18 Jan 2024, 5:14 pm
Sanofi et al. [read post]
11 Jan 2024, 9:31 pm
Sanofi. [read post]
11 Jan 2024, 12:59 pm
Sanofi, 143 S. [read post]
9 Jan 2024, 3:30 pm
Sanofi. [read post]
9 Jan 2024, 3:30 pm
Sanofi. [read post]
9 Jan 2024, 1:15 pm
Sanofi the Supreme Court spoke. [read post]
9 Jan 2024, 1:15 pm
Sanofi the Supreme Court spoke. [read post]
31 Dec 2023, 4:29 pm
Sanofi In this case, the Supreme Court considered the validity of certain patents on antibodies used to lower cholesterol under the Patent Act’s enablement requirement (35 U.S.C. 112(a)). [read post]
29 Dec 2023, 4:00 am
Sanofi U.S. [read post]
27 Dec 2023, 5:51 am
Firstly, in the Amgen v Sanofi case, the well-publicized woes of the CMS on day one saw the parties competing for who could get their hard copy filing before the Court first. [read post]
22 Dec 2023, 5:29 am
PatKat reviewing the yearIt is time once more for the IPKat patent year in review! [read post]
20 Dec 2023, 5:00 am
Sanofi will affect innovation and the pharmaceutical industry. [read post]
15 Dec 2023, 1:16 pm
The post Sanofi Abandons Deal For Rare Disease Drug Amid FTC’s Monopoly Concerns appeared first on Above the Law. [read post]
15 Dec 2023, 12:48 pm
This week in Other Barks & Bites: a group of authors filed a trimmed-down lawsuit against Meta accusing the company of infringing copyright to train generative AI models; the FTC authorizes a lawsuit against Sanofi accusing a potential acquisition of being a move to monopolize Pompe disease drug development; and Chinese courts publish rulings to combat malicious trademarks. [read post]
15 Dec 2023, 12:48 pm
This week in Other Barks & Bites: a group of authors filed a trimmed-down lawsuit against Meta accusing the company of infringing copyright to train generative AI models; the FTC authorizes a lawsuit against Sanofi accusing a potential acquisition of being a move to monopolize Pompe disease drug development; and Chinese courts publish rulings to combat malicious trademarks. [read post]
14 Dec 2023, 10:00 pm
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
14 Dec 2023, 12:15 pm
Sanofi decisions, respectively. [read post]
14 Dec 2023, 12:15 pm
Sanofi decisions, respectively. [read post]
13 Dec 2023, 1:29 am
The appeal case T 1356/21 related to the novelty of Sanofi's patent (EP2571517). [read post]
